Company News
-
March 19, 2024
bioMérieux and the Food and Drug Administration Launch Research Collaboration to Improve Microbial Detection Tools to Combat Food-Borne Pathogens
bioMérieux has entered into a strategic research collaboration with the US Food and Drug Administration (FDA), Center for Food Safety and Applied Nutrition (CFSAN), Offices of Applied Research and Safety Assessment (OARSA) and Regulatory Science (ORS) to develop tools to combat food-borne pathogens. -
January 18, 2024
bioMérieux and the University of Pittsburgh Form Research Partnership
A strategic R&D partnership between bioMérieux and the University of Pittsburgh (Pitt) has been launched, paving the way for many innovative and collaborative research projects. -
December 18, 2023
CATTI and bioMérieux Canada are joining forces to support the development of a qualified workforce in advanced therapies
CATTI, Canadian Advanced Therapies Training Institute, and bioMérieux Canada are combining their respective strengths to enhance the training of the workforce in advanced therapies and the production of quality control solutions (for the pharmaceutical industries). -
December 13, 2023
bioMérieux celebrates the First Graduating Class of its Academy of microbiology in Latin America
In 2020, bioMérieux launched an innovative educational program in Latin America dedicated to healthcare professionals to strenghten their understanding and practice of microbiology. -
November 28, 2023
A Stronger Business Relationship to Enhance bioMérieux’s BIOFIRE® SPOTFIRE® Presence in the US Outpatient Diagnostic Market
bioMérieux has strengthened its relationship with McKesson Medical-Surgical, a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere.